1,182
Views
56
CrossRef citations to date
0
Altmetric
Review

Candida auris: a worrisome, globally emerging pathogen

, &
Pages 819-827 | Received 26 May 2017, Accepted 04 Aug 2017, Published online: 14 Aug 2017

References

  • Mikulska M, Del Bono V, Ratto S, et al. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol. 2012;8(8):755–765.
  • Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44.
  • Centers for Disease Control and Prevention. Clinical alert to US healthcare facilities: global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. [Internet]. Atlanta: CDC; 2017.
  • Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290. .
  • Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–140.
  • Okinda N, Kagotho E, Castanheira M, et al. Candidemia at a referral hospital in Sub-Saharan Africa: emergence of Candida auris as a major pathogen. European Conference on Clinical Microbiology and Infectious diseases: May 2014: Barcelona, Spain[ Poster Session]
  • Magobo RE, Corcoran C, Seetharam S, et al. Candida auris-associated candidemia, South Africa. Emerg Infect Dis. 2014;20(7):1250–1251.
  • Calvo B, Melo AS, Perozo-Mena A, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369–374.
  • Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72(6):1794–1801.
  • Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35.
  • Kim MN, Shin JH, Sung H, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):e57–61.
  • Kumar D, Banerjee T, Pratap CB, et al. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015;9(4):435–437.
  • Khillan V, Rathore N, Kathuria S, et al. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Rep. 2014;1. DOI:10.1099/jmmcr.0.T00018.
  • Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142.
  • Azar MM, Turbett SE, Fishman JA, et al. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis. 2017.
  • Choi HI, An J, Hwang JJ, et al. Otomastoiditis caused by Candida auris: case report and literature review. Mycoses. 2017;60:488–492.
  • Morales-Lopez SE, Parra-Giraldo CM, Ceballos-Garzon A, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23(1):162–164.
  • Chowdhary A, Anil Kumar V, Sharma C, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33(6):919–926.
  • Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–1673.
  • Ben-Ami R, Berman J, Novikov A, et al. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017;23(1).
  • Emara M, Ahmad S, Khan Z, et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis. 2015;21(6):1091–1092.
  • Al-Siyabi T, Al Busaidi I, Balkhair A, et al. First report of Candida auris in Oman: clinical and microbiological description of five candidemia cases. J Infect. 2017;S0163-4453(17):30164-0.
  • Ruiz Gaitan AC, Moret A, Lopez Hontangas JL, et al. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol. 2017;34(1):23–27.
  • Tsay S, Welsh RM, Adams EH, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities - United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66(19):514–515.
  • Haynes K. Virulence in Candida species. Trends Microbiol. 2001;9(12):591–596.
  • Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61:5.
  • Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016;1:4.
  • Oh BJ, Shin JH, Kim MN, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycology. 2011;49(1):98–102.
  • Sherry L, Ramage G, Kean R, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–331.
  • Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections? J Hosp Infect. 2016;94(3):209–212.
  • Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65(44):1234–1237.
  • Kathuria S, Singh PK, Sharma C, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and etest method. J Clin Microbiol. 2015;53(6):1823–1830.
  • Prakash A, Sharma C, Singh A, et al. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect. 2016;22(3):277.e1-9.
  • Chatterjee S, Alampalli SV, Nageshan RK, et al. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015;16:686.
  • Lepak AJ, Zhao M, Berkow EL, et al. Pharmacodynamic optimization for treatment of invasive Candida auris infection. Antimicrob Agents Chemother. 2017;61:e00791-17.
  • Arendrup MC, Prakash A, Meletiadis J, et al. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother. 2017;61(6):e00485-17.
  • Kim TH, Kweon OJ, Kim HR, et al. Identification of uncommon Candida species using commercial identification systems. J Microbiol Biotechnol. 2016;26(12):2206–2213.
  • Girard V, Mailler S, Chetry M, et al. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 2016;59(8):535–538.
  • Candida auris Interim Recommendations for Healthcare Facilities and Laboratories [Internet] Atlanta, CDC 2016.
  • Mizusawa M, Miller H, Green R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol. 2017;55(2):638–640.
  • Kordalewska M, Zhao Y, Lockhart SR, et al. Rapid and accurate molecular identification of the emerging multidrug resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445–2452.
  • Borman AM, Szekely A, Johnson EM. Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Medical mycology. 2017;55(5).
  • European Centre for Disease Prevention and Control. Candida auris in healthcare settings –Europe Internet. Stockholm:ECDC; 2016.
  • Cadnum J. Effectiveness of disinfectants against Candida auris and other Candida species. [Poster Presentation#243] Society for Healthcare Epidemiology of America, March 2017.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.